As the field shifts towards genetic-first and aetiology-based classification, some patients meeting full electroclinical criteria for EMAtS may also fulfil the definition of a DEE, particularly when associated with moderate/severe developmental delay or a known genetic diagnosis (e.g. SYNGAP1, SCN2A). This evidence concerns the gene SCN2A and Global developmental delay.